Trial Gives New Guidance for Choosing Initial PsA Treatment
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than escalating the methotrexate dose alone.
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than escalating the methotrexate dose alone.
Most cancer cases in England occur in White individuals, broadly reflecting the ethnic makeup of the population, but with some notable exceptions in minority groups.
There was a more than 40% leap in incidence after the USPSTF recommended against routine screening in healthy men.
Contrary to national guidelines, more than a quarter of US cancer centers do not recommend shared decision-making before initiating PSA screening.
The combination therapy outperformed methotrexate monotherapy as a treatment option for patients with psoriatic arthritis (PsA), though it did come with an increase in side effects.